ERBB2 and cancer: Of 10 articles that reported the HER2 (human epidermal growth factor receptor 2) status, one article included all HER2-positive cancers, while the remaining articles (n = 9) had 10–19% HER2-positive cancers (n = 6) or 5–10% HER2-positive cancers (n = 3).